SEC Form 4 · accession 0001179110-16-021878
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent Milano
Officer — President & CEO · Director
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 8:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 15, 2016 | P | 40,000 | $1.97 | A | 246,527 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported herein reflects an aggregate of purchases at per share prices ranging from $1.94 to $2.00 inclusive. The Reporting Person further undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the manner of shares purchased at each separate price.
- F2Includes 6,527 shares acquired under the IDRA employee stock purchase plan on February 29, 2016.